Chronic Lymphocytic Leukemia
Open Access
- 1 October 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 4 (5) , 352-369
- https://doi.org/10.1634/theoncologist.4-5-352
Abstract
The diagnosis and management of chronic lymphocytic leukemia (CLL) is reviewed, including the basic aspects of epidemiology, molecular biology, and cytogenetics with clinical relevance. The importance of immunophenotype in the differential diagnosis of other lymphoproliferative disorders related to CLL, staging, prognostic factors, promising new drugs, and approaches is summarized.Keywords
This publication has 97 references indexed in Scilit:
- IL4 production and increased CD30 expression by a unique CD8+ T‐cell subset in B‐cell chronic lymphocytic leukaemiaBritish Journal of Haematology, 1999
- Genetic abnormalities in chronic lymphocytic leukemia and their clinical and prognostic implicationsCancer Genetics and Cytogenetics, 1997
- Subcutaneous CAMPATH‐1H in fludarabine‐resistant/relapsed chronic lymphocytic and B‐prolymphocytic leukaemiaBritish Journal of Haematology, 1997
- Pentostatin in Prolymphocytic Leukemia: Phase II Trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study GroupJNCI Journal of the National Cancer Institute, 1993
- Treatment of advanced chronic lymphocytic leukemia by fludarabineAnnals of Hematology, 1991
- Pentostatin in Refractory Chronic Lymphocytic Leukemia: A Phase II Trial of the European Organization for Research and Treatment of CancerJNCI Journal of the National Cancer Institute, 1990
- Intravenous Immunoglobulin for the Prevention of Infection in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 1988
- Rapid transient reversal of anemia and long-term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disordersThe American Journal of Medicine, 1988
- The Membrane Phenotype of T‐Prolymphocytic LeukaemiaScandinavian Journal of Haematology, 1982
- A clinical staging system for chronic lymphocytic leukemia.Prognostic significanceCancer, 1977